Moderna, Inc. (NASDAQ:MRNA) is among the 13 Best S&P 500 Stocks to Buy According to Wall Street Analysts, based on upside potential. However, 2025 has been a challenging year for the company, with a ...

Moderna (NASDAQ:MRNA – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $33.00 to $26.00 in a report issued on Thursday,Benzinga reports. The firm currently has an ...

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, overshadowing lower-than-expected second-quarter loss and sending its shares ...

Moderna, Inc. MRNA will release earnings results for the second quarter, before the opening bell on Friday, Aug. 1. Analysts expect the Cambridge, Massachusetts-based company to report quarterly ...

Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and Drug Administration’s top vaccine official has resigned. Watch these ...